Trident Texofab Forfeits 9.11 Lakh Warrants, Loses ₹1.6 Cr

Trident Texofab Ltd announced the forfeiture of 9,11,479 fully convertible warrants during its Board Meeting on July 2, 2026. These warrants, originally allotted on December 23, 2024, were issued on a preferential basis to non-promoter public category investors at an issue price of ₹70 per warrant. The forfeiture occurred because the warrant holders failed to exercise their option to convert the warrants into equity shares within the stipulated 18-month period, which ended on June 22, 2026. Consequently, the upfront subscription amount paid for these warrants, totaling ₹1,59,50,882.50 (25% of the issue price), has been forfeited by the company. The company stated that this action has no impact on its issued, subscribed, or paid-up equity share capital.